RIPE-KG · Version 1.1.0 · Resource

ripekg:work/RIPEWDE23DE5290E9E220

https://w3id.org/ripe/ripe-kg/work/RIPEWDE23DE5290E9E220
SubjectPredicateObject
ripekg:work/10.1016%2Fj.jclinepi.2025.111751Measuring the environmental impact of health interventions in randomized controlled trials – A scoping review http://purl.org/spar/cito/cites ripekg:work/RIPEWDE23DE5290E9E220Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial
ripekg:work/RIPEWDE23DE5290E9E220Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial dcterms:title Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial
ripekg:work/RIPEWDE23DE5290E9E220Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial rdf:type node1
ripekg:work/RIPEWDE23DE5290E9E220Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial rdf:type http://purl.org/spar/fabio/Work
ripekg:work/RIPEWDE23DE5290E9E220Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial rdf:type rdfs:Resource
ripekg:work/RIPEWDE23DE5290E9E220Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial rdf:type owl:Thing
ripekg:work/RIPEWDE23DE5290E9E220Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial rdf:type prov:Entity
ripekg:work/RIPEWDE23DE5290E9E220Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial rdf:type ripe:WorkWork